PAA 2.50% 20.5¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-497

  1. 1,066 Posts.
    lightbulb Created with Sketch. 2158
    Hi Theoc and Havenots,

    In relation to pneumonia I am unsure. There may be a cross negative synergy of immune system. Seems that T cell mediated hypersensitivity reaction and a peculiar auto immune response happens . To the best of my knowledge there has been few animal or in vitro studies has identified the pathogenesis.
    So at the moment . No.

    In relation to the Science Series just released. The information on that is in huge detail. I specialise in a few drugs but that is way way over my head. Terrific presentation 10/10..


    In relation to the PAA announcement just out. Isn't that just what the Scientist ordered.

    Cheers Kpax


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.